Takara Bio, Inc.

16
Strong Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3460200003
JPY
768.00
-4 (-0.52%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Operating Income
45,039.00
43,505.00
78,142.00
67,699.00
46,086.00
34,565.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
45,039.00
43,505.00
78,142.00
67,699.00
46,086.00
34,565.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
Operating Expenses
20.00
23.00
24.00
23.00
24.00
7.00
General and Administration Expenses
16,907.00
15,581.00
15,649.00
14,200.00
12,374.00
10,961.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
42,776.00
40,502.00
57,601.00
38,797.00
32,133.00
28,289.00
Operating Profit (PBDIT) excl Other Income
2,263.00
3,003.00
20,541.00
28,902.00
13,953.00
6,276.00
Other Income
216.00
82.00
69.00
-586.00
-325.00
48.00
Operating Profit (PBDIT)
6,960.00
8,106.00
25,345.00
32,465.00
17,414.00
9,854.00
Interest
20.00
23.00
24.00
23.00
24.00
7.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
4,481.00
5,021.00
4,735.00
4,149.00
3,786.00
3,530.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
1,997.00
2,853.00
21,224.00
27,532.00
13,552.00
5,433.00
Provision for Tax
910.00
1,343.00
5,176.00
7,624.00
3,971.00
1,601.00
Profit After Tax
1,042.00
1,481.00
16,012.00
19,850.00
9,547.00
3,820.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
8.65
12.29
132.97
164.84
79.28
31.72
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 3.53% vs -44.33% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -24.64% vs -85.38% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -13.04% vs -4.17% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is -29.64% vs -90.75% in Mar 2024

Compare Profit and Loss Results of Takara Bio, Inc.
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
No of Months
12
12
Operating Income
45,039.00
3,61,593.00
-3,16,554.00
-87.54%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
45,039.00
3,61,593.00
-3,16,554.00
-87.54%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
0.00
0.00
0%
Operating Expenses
20.00
5,262.00
-5,242.00
-99.62%
General and Administration Expenses
16,907.00
1,44,249.00
-1,27,342.00
-88.28%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
42,776.00
3,39,618.00
-2,96,842.00
-87.40%
Operating Profit (PBDIT) excl Other Income
2,263.00
21,975.00
-19,712.00
-89.70%
Other Income
216.00
2,481.00
-2,265.00
-91.29%
Operating Profit (PBDIT)
6,960.00
52,327.00
-45,367.00
-86.70%
Interest
20.00
5,262.00
-5,242.00
-99.62%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
4,481.00
27,871.00
-23,390.00
-83.92%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
1,997.00
19,194.00
-17,197.00
-89.60%
Provision for Tax
910.00
8,458.00
-7,548.00
-89.24%
Profit After Tax
1,042.00
10,484.00
-9,442.00
-90.06%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
8.6451
82.5799
-73.93
-89.53%
Profit And Loss - Net Sales
Net Sales 45,039.00 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 3.53% vs -44.33% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2,263.00 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is -24.64% vs -85.38% in Mar 2024

Profit And Loss - Interest
Interest 20.00 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is -13.04% vs -4.17% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 1,042.00 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is -29.64% vs -90.75% in Mar 2024